Microenvironment regulation

Microenvironment regulation is a broad therapeutic strategy focused on modulating the local ecosystem surrounding a primary site of disease, most commonly the tumor microenvironment (TME) (NCI, 2023). This microenvironment is a complex network consisting of immune cells, blood vessels, fibroblasts, and the extracellular matrix (ECM), all of which interact to influence disease progression and treatment resistance (Nature Reviews Cancer, 2021). Rather than targeting a single protein or receptor on a diseased cell, microenvironment regulation involves multi-faceted approaches such as inhibiting angiogenesis, reprogramming immunosuppressive cells, and modifying physical barriers to drug delivery (PubMed, PMC7460144). For instance, checkpoint inhibitors regulate the immune microenvironment to restore anti-tumor activity, while anti-angiogenic agents normalize vasculature to improve the delivery of cytotoxic agents (NIH, 2024). Consequently, this concept represents a paradigm shift from cell-intrinsic targeting to holistic management of the niche supporting the disease. Understanding these regulatory pathways is critical for the development of modern combination therapies and overcoming drug resistance in oncology and chronic inflammatory conditions.

Other names

Tumor microenvironment modulationTME regulationStromal modulationExtracellular matrix remodelingNiche regulation

Modulation of the surrounding cellular and non-cellular components, such as immune cells, fibroblasts, and the extracellular matrix, to inhibit disease progression or enhance the efficacy of other therapies (Nature Reviews Cancer, 2021).